Tweenvest Stocks

NFL Biosciences SA (ENXTPA: ALNFL)

Health Care · Biotechnology · FR

€0.67

-10.32% today · -48.4% 1Y

NFL Biosciences SA (ENXTPA: ALNFL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.54M and employs 4 people.

Over the last twelve months the share price has lost 48.4%, trading between 0.64 and 1.85.

Tweenvest scores NFL Biosciences SA across four factors: quality 56/100, value 25/100. Its strongest factor is quality.

ALNFL price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$9.54M
Revenue (TTM)
$221.00
P/E
—
EPS
-0.26
Dividend yield
—
Beta (5Y)
1.28
52-week high
€1.85
52-week low
€0.64
Avg volume (3M)
—
Shares outstanding
12.67M
Employees
4
Next earnings
—

About NFL Biosciences SA

Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S.A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking. Their most advanced therapeutic candidate, NFL-101, derived from tobacco, is currently progressing through Phase III clinical trials specifically designed to combat smoking addiction. Additionally, the company's research pipeline features NFL-201, an extract blending cannabis and tobacco, and NFL-301, a botanical formulation rooted in traditional Chinese medicine, both of which are undergoing preclinical assessment.

ISIN
FR0014003XT0
Founded
2006
Listed since
Jul 5, 2021
Exchange
Euronext Paris
Currency
EUR
CompanyMarket capPriceDay
Adaptimmune Therapeutics plcOTCPK: ADAP.Y$9.81M$0.04+45.10%
Zeo ScientifiX, Inc.OTCPK: ZEOX$9.80M$1.25-8.09%
CRISM Therapeutics CorporationAIM: CRTX$9.69M£0.09-5.13%
Oncotelic Therapeutics, Inc.OTCPK: OTLC$9.61M$0.02-17.00%
Moleculin Biotech, Inc.NasdaqCM: MBRX$9.48M$0.42-12.90%
PeopleBio, Inc.KOSDAQ: A304840$9.47M₩——
Celestra Inc.KOSDAQ: A352770$9.28M₩——
Vivesto ABOM: VIVE$9.20MSkr8.34-7.44%

Browse every Biotechnology company →

Figures last refreshed Oct 4, 2026.